Sandoval-Sus, J., & Chavez, J. C. (2021). The role of axicabtagene ciloleucel as a treatment option for patients with follicular/marginal zone lymphoma. Ther Adv Hematol.
Chicago Style CitationSandoval-Sus, Jose, i Julio C. Chavez. "The Role of Axicabtagene Ciloleucel As a Treatment Option for Patients With Follicular/marginal Zone Lymphoma." Ther Adv Hematol 2021.
Cita MLASandoval-Sus, Jose, i Julio C. Chavez. "The Role of Axicabtagene Ciloleucel As a Treatment Option for Patients With Follicular/marginal Zone Lymphoma." Ther Adv Hematol 2021.
Atenció: Aquestes cites poden no estar 100% correctes.